NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine - https://archive.org/web/.
Read Original Story

Chinese Herbs Equal to Tamiflu in Reducing H1N1 Fever: Study

Rating

3 Star

Chinese Herbs Equal to Tamiflu in Reducing H1N1 Fever: Study

Our Review Summary

This story was about a study comparing a Chinese herbal mixture to Tamiflu for the treatment of H1N1 flu (also called swine flu). Although it communicated the basics of the study well enough, it didn’t provide important information on costs or quantify the benefits with sufficient precision. It also lacked crucial context that a truly independent observer might have provided — specifically, that the patients included in the study (healthy adults with very mild cases) are not the kind of people for whom Tamiflu makes a big difference, as these patients typically get better quickly on their own without treatment. What’s truly needed is an alternative treatment for patients with severe cases who don’t have access to antiviral drugs. This study gets us a step closer to determining whether this herb mixture might be effective for those patients, but it doesn’t address the question directly.

 

Why This Matters

In the recent worldwide flu pandemic, many patients in poor countries did not have access to antiviral drugs such as Tamiflu. It is important to know whether locally available alternatives, such as this Chinese herbal remedy, are useful for treating the disease.

Consumers in the developed world also want to know if popular herbal medicines are worth taking. Stories that report on these kinds of alternative remedies should focus on efficacy and risks, so that consumers can weigh these against the cost and outcome of seeing a physician for a prescription medication.

Criteria

Does the story adequately discuss the costs of the intervention?

Not Satisfactory

The story says the herb mixture is much less expensive than Tamiflu. But how much does Tamiflu (and the related physician visit) cost? Providing an actual price tag would have dispelled any uncertainty.

Does the story adequately quantify the benefits of the treatment/test/product/procedure?

Not Satisfactory

Not enough information here. The story says that Tamiflu, the herb mixture, and the combination of the two “helped to resolve fever sooner than no intervention whatsoever.” But the story never tells us how much sooner the fevers resolved. As it turns out, the fastest resolution was seen in the combination group (about 15 hours from onset), whereas the control group fevers typically resolved after about 26 hours. There was also no discussion of the fact that other symptoms (cough, sore throat, etc) were not affected by any of the treatments.

Does the story adequately explain/quantify the harms of the intervention?

Satisfactory

The story mentions adverse effects that have been associated with ephedra, one of the constituents of the herbal treatment being tested. It also says that minimal side effects were seen in all treatment groups of this study. The story could have commented on other possible side effects of herbals, such as potential interactions with other medications.

Does the story seem to grasp the quality of the evidence?

Satisfactory

We would have liked to see more qualifiers, specifically regarding the fact that these were patients with very mild disease. We don’t know how effective the herb mixture would be for patients with more severe cases of H1N1 flu, which is where Tamiflu has a more pronounced effect. The story does, however, quote an expert who counsels readers not to self-medicate and to see a doctor. That advice, together with a generally adequate description of the study, allows this story to squeak by with a satisfactory.

Does the story commit disease-mongering?

Not Satisfactory

Although the writer didn’t hype the problem of influenza (which does result in a large number of deaths every year), the majority of those with the flu do not require treatment. So the story edges into disease-mongering territory when it suggests that Tamiflu was the “treatment of choice” for most cases of H1N1. In fact, antiviral drugs were unconditionally recommended by WHO guidelines only for certain groups, such as those with severe illness or who were at risk of developing a severe illness. Patients like those in this study who had “very mild” cases of the flu were not necessarily candidates for treatment with antivirals because their illnesses were typically short and self-limited and would not be substantially affected by taking Tamiflu. In addition, overuse of antivirals encourages the development of drug resistant virus strains. By failing to draw this distinction, the story leads readers to believe that every case of H1N1, even very mild ones, should be treated with Tamiflu, which is not accurate.

Does the story use independent sources and identify conflicts of interest?

Not Satisfactory

The story provides commentary from one of the study authors and a representative of the dietary supplement industry. Neither of these sources could be called truly independent.  A primary care physician or public health person could have provided perspective about who is a candidate for treatment with antiviral drugs.

Does the story compare the new approach with existing alternatives?

Not Satisfactory

The story never mentions vaccines, which of course can prevent the H1N1 flu from developing in the first place. Also, existing medications such as acetaminophen and ibuprofen can ease fever and other flu symptoms.

Does the story establish the availability of the treatment/test/product/procedure?

Satisfactory

The description of the herb mixture’s availability is good enough for a satisfactory. The story says that “finding the medicine in the United States is difficult, if not impossible, given that it contains the stimulant ephedra.”  The story could have noted that ephedra’s use remains legal in traditional Chinese medicine (the application being discussed in this story), but patients may only obtain the medicine through a Chinese medicine practitioner.

Does the story establish the true novelty of the approach?

Satisfactory

The story notes that herbal remedies like the one tested in this study have been used for thousands of years in China.

Does the story appear to rely solely or largely on a news release?

Satisfactory

This story was not based on a news release.

Total Score: 5 of 10 Satisfactory

Comments

Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.